Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service pacemaker, ICD & CRT implantation cases in North Carolina: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (249 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 104 | 5,834 | 40% |
| 2020 | 95 | 5,360 | 43% |
| 2021 | 98 | 5,525 | 48% |
| 2022 | 95 | 4,994 | 52% |
| 2023 | 97 | 5,034 | 56% |
| 2024 | 100 | 4,907 | 59% |
| 2025 from claims | – | 4,862 4,462–5,144 | 61% |
| 2026 forecast | – | 4,925 4,333–5,683 | 62% |
| 2027 forecast | – | 4,967 4,247–5,920 | 62% |
| 2028 forecast | – | 5,007 4,178–6,131 | 63% |
| 2029 forecast | – | 5,044 4,120–6,326 | 64% |
| 2030 forecast | – | 5,078 4,068–6,508 | 65% |
Pacemaker, leadless, ICD, S-ICD, CRT, and generator replacements. Professional codes (what the surgeon bills): CPT 33206, 33207, 33208, 33274, 33249, 33270, 33262, 33263, 33264; the hospital bills MS-DRG 242, 243, 244, 226, 227, 275, 276, 277.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 25% of the cases CMS names in North Carolina; 60 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 47% inpatient hospital, 53% hospital outpatient.
| Forecast, Medicare FFS | Inpatient | Hospital outpatient |
|---|---|---|
| 2026 · ~4,900 | ~2,300 | ~2,600 |
| 2027 · ~5,000 | ~2,400 | ~2,600 |
| 2028 · ~5,000 | ~2,400 | ~2,600 |
The forecast’s cases at the projected mix.
The mix is steady: the trend moves no setting by a point or more by 2028.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Florida | 252 | 13,475−2.8%/yr | −2.8%/yr | 6.3 | 8% | 13,600 in 2030+0.2%/yr |
| Texas | 220 | 11,944−3.2%/yr | −3.2%/yr | 5.8 | 7% | 12,500 in 2030+0.7%/yr |
| Virginia | 89 | 5,169−2.2%/yr | −2.2%/yr | 5.1 | 6% | 5,360 in 2030+0.6%/yr |
| Tennessee | 79 | 4,585−3.7%/yr | −3.7%/yr | 6.8 | 1% | 4,450 in 2030−0.5%/yr |
| Georgia | 88 | 4,562−3.7%/yr | −3.7%/yr | 5.5 | 0% | 5,000 in 2030+1.5%/yr |
| South Carolina | 68 | 3,818−0.9%/yr | −0.9%/yr | 5.8 | 1% | 4,480 in 2030+2.7%/yr |
| Maryland | 50 | 3,380−1.5%/yr | −1.5%/yr | 3.9 | 1% | 3,330 in 2030−0.2%/yr |
| Arkansas | 40 | 2,434−5.8%/yr | −5.8%/yr | 6.7 | 0% | 2,160 in 2030−1.9%/yr |
| Alabama | 51 | 2,358−6.8%/yr | −6.8%/yr | 5.6 | 0% | 2,180 in 2030−1.3%/yr |
| Oklahoma | 41 | 2,342−5.8%/yr | −5.8%/yr | 5.0 | 3% | 2,290 in 2030−0.4%/yr |
| Louisiana | 38 | 2,141−6.6%/yr | −6.6%/yr | 5.5 | 9% | 1,980 in 2030−1.3%/yr |
| Kentucky | 43 | 2,124−7.2%/yr | −7.2%/yr | 4.8 | 0% | 1,980 in 2030−1.2%/yr |
| Mississippi | 27 | 1,618−8.6%/yr | −8.6%/yr | 4.5 | 6% | 1,500 in 2030−1.3%/yr |
| West Virginia | 18 | 1,108−1.5%/yr | −1.5%/yr | 5.5 | 0% | 1,020 in 2030−1.4%/yr |
| Delaware | 13 | 724−4.8%/yr | −4.8%/yr | 4.3 | 0% | 790 in 2030+1.4%/yr |
| District of Columbia | 10 | 494−2.1%/yr | −2.1%/yr | 8.1 | 0% | 510 in 2030+0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| EP ablation | 76 | 3,911+8.1%/yr | +8.1%/yr | 3.30.9× | 0% | 6,900 in 2030+9.9%/yr |
| LAA occlusion & loop recorders | 76 | 2,760+8.6%/yr | +8.6%/yr | 2.40.6× | 7% | 4,660 in 2030+9.1%/yr |
Pacemaker, ICD & CRT implantation in every state, and its device makers · Every procedure market in North Carolina · Every state · Compare with Florida
Boston Scientific leads with 28% of company spending on these surgeons in 2025, level with 2024.
In 2025, 9 companies reported engagement with North Carolina’s surgeons worth $494K in consulting, speaking, meals and travel tied to these products, about $4,937 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 339 clearances and approvals in the category, 3 recalled product lines (2 Class I). A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
For CPT 33206 (insert heart pm atrial), commercial plans pay North Carolina’s hospitals a median of $10K, from $4,651 at the lowest to $10K at the highest, across 8 hospitals that publish a price.
Each hospital’s median over its commercial plans, from the machine-readable files hospitals must post; not every hospital is loaded.